Fulyzaq

Active Ingredient(s): Crofelemer
FDA Approved: * December 31, 2012
Pharm Company: * SALIX PHARMS
Category: Gastrointestinal

Crofelemer (USAN, trade name Mytesi) is an antidiarrheal indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy.[1] Other possible uses include diarrhea in children, acute infectious diarrhea, and diarrhea in patients with irritable bowel syndrome.[2] It is a purified oligomeric proanthocyanidin from "dragon's blood", the sap of the South American tree Croton lechleri.[3] Crofele... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Fulyzaq 125 mg Enteric Coated Tablet

NDC: 65649-802

Labeler:

Salix Pharmaceuticals, Inc.

Fulyzaq 125 mg Oral Tablet, Coated

NDC: 70564-802

Labeler:

Napo Pharmaceuticals, Inc.